Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 2 408 INR 1.09% Market Closed
Market Cap: 20.5B INR
Have any thoughts about
Hester Biosciences Ltd?
Write Note

Hester Biosciences Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hester Biosciences Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Hester Biosciences Ltd
NSE:HESTERBIO
Operating Income
â‚ą470.6m
CAGR 3-Years
-9%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Operating Income
-â‚ą202.8m
CAGR 3-Years
-119%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Operating Income
-â‚ą9.5m
CAGR 3-Years
55%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Operating Income
â‚ą69.3m
CAGR 3-Years
12%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Operating Income
â‚ą15B
CAGR 3-Years
18%
CAGR 5-Years
6%
CAGR 10-Years
12%
Panacea Biotec Ltd
NSE:PANACEABIO
Operating Income
-â‚ą485.1m
CAGR 3-Years
-26%
CAGR 5-Years
19%
CAGR 10-Years
N/A
No Stocks Found

Hester Biosciences Ltd
Glance View

Market Cap
20.5B INR
Industry
Biotechnology

Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. The company is headquartered in Ahmedabad, Gujarat and currently employs 584 full-time employees. Its segments include Poultry division and Animal division. The company provides over 40 products across poultry vaccines (live and inactivated), animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. The company manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. The company offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

HESTERBIO Intrinsic Value
1 593.33 INR
Overvaluation 34%
Intrinsic Value
Price

See Also

What is Hester Biosciences Ltd's Operating Income?
Operating Income
470.6m INR

Based on the financial report for Sep 30, 2024, Hester Biosciences Ltd's Operating Income amounts to 470.6m INR.

What is Hester Biosciences Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-3%

Over the last year, the Operating Income growth was 25%. The average annual Operating Income growth rates for Hester Biosciences Ltd have been -9% over the past three years , -3% over the past five years .

Back to Top